In prostate cancer cells, ovarian cancer cells, and osteosarcoma, JNK signaling is activated by DKK1 via a β-catenin-independent pathway and promotes cell invasion or tumor growth. The gene discussed is MAPK8; the disease is prostate carcinoma.